Popular Articles

Johnson & Johnson's Research Reflecting New Washington Policies
Health care supplier Johnson & Johnson will focus on new treatments and improved tests for cancer and other diseases for which company perceives unmet needs, like diabetes, hepatitis C, and HIV, as well as using new, Washington-supported research techniques to gauge their effectiveness, researchers and executives said at a briefing with analysts, BusinessWeek reports.
drugs without prescription
Survey Finds Surgical Residents View Duty Hour Regulations As A Hindrance To Training
Results of a survey published in the July issue of the Journal of the American College of Surgeons show that a large subset of surgical residents consider duty hour regulations (DHR) a significant barrier to their surgical education and express a desire for flexibility to work longer hours than current restrictions allow.
News of the day
80% Of Canadians Want Airlines To Offer Pet-Free Flights: Lung Association Poll
Eighty percent of Canadians believe Canada"s airlines should offer some pet-free flights to protect the health and safety of passengers and crew members, according to a new survey released today by The Canadian Lung Association. The findings come as Air Canada prepares to join WestJet in allowing pets to travel in the passenger cabin of airplanes - pet allergens can trigger serious or even life-threatening reactions in people with lung diseases like asthma and COPD.
Public Health

Miami-Dade, Blue Cross Announce Low-Cost PPO Aimed At County's Uninsured

Florida"s Miami-Dade County and BlueCross BlueShield of Florida on Tuesday announced a new low-cost health plan, called Miami-Dade Blue, aimed at helping the estimated 600,000 uninsured county residents, the Miami Herald reports. The plan -- which costs taxpayers nothing -- is a traditional PPO, with no pre-approvals or referrals and will cost a healthy 35-year-old male about $100 per month. Miami-Dade Blue has a $250 deductible and will cover 90% of in-network hospital costs and 100% of fees for in-network lab tests after the deductible is met. The copayment for generic drugs is $10 per prescription; the plan will not offer coverage for brand-name prescriptions.The plan is being offered to individuals younger than age 65 and to small employers with up to 50 workers. Businesses will be guaranteed coverage if 70% of employees take part in the plan and the owner pays at least 50% of the premiums; however, individuals with costly pre-existing health conditions likely will be denied coverage. The plan has an annual out-of-pocket limit of $2,500 and a lifetime benefit of $5 million. About 1,500 physicians agreed to be part of the Miami-Dade Blue network, while 20 clinics and seven hospitals are in the plan"s network (Dorschner, Miami Herald, 5/27). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):